0.308

1.55% 0.0047

After Hours: .31 0.002 +0.65%

Senseonics Holdings Inc (SENS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Senseonics Holdings Inc stock is traded at $0.308, with a volume of 3.14M. It is up +1.55% in the last 24 hours and down -8.88% over the past month. Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Previous Close:

$0.3033

Open:

$0.3

24h Volume:

3.14M

Relative Volume:

0.62

Market Cap:

$181.88M

Revenue:

$22.39M

Net Income/Loss:

$-60.39M

P/E Ratio:

-1.6942

EPS:

-0.1818

Net Cash Flow:

$-70.51M

1W Performance:

-2.93%

1M Performance:

-8.88%

6M Performance:

-30.63%

1Y Performance:

-48.29%

1-Day Range:

$0.30

$0.3098

1-Week Range:

$0.295

$0.329

52-Week Range:

$0.2751

$0.75

Senseonics Holdings Inc Stock (SENS) Company Profile

Name

Senseonics Holdings Inc

Sector

Healthcare (1200)

Industry

Medical Devices (153)

Phone

301-515-7260

Address

20451 Seneca Meadows Parkway, Germantown, MD

Employee

Twitter

@senseonics

Next Earnings Date

2024-11-07

Latest SEC Filings

SENS's Discussions on Twitter

Compare SENS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SENS Senseonics Holdings Inc	0.308	181.88M	22.39M	-60.39M	-70.51M	-0.1818
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-19-23	Initiated	Jefferies	Underperform
Aug-19-21	Initiated	H.C. Wainwright	Buy
Apr-01-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Mar-05-21	Downgrade	Raymond James	Mkt Perform → Underperform
Jan-21-21	Downgrade	BTIG Research	Buy → Neutral
Jan-20-21	Downgrade	Craig Hallum	Hold → Sell
Aug-11-20	Upgrade	BTIG Research	Neutral → Buy
Aug-11-20	Upgrade	Craig Hallum	Sell → Hold
Mar-13-20	Downgrade	BTIG Research	Buy → Neutral
Mar-13-20	Downgrade	Guggenheim	Buy → Neutral
Nov-13-19	Downgrade	Canaccord Genuity	Buy → Hold
Nov-13-19	Downgrade	Craig Hallum	Buy → Hold
Oct-23-19	Initiated	Stifel	Buy
Jul-05-19	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-29-19	Initiated	Piper Jaffray	Neutral
Aug-24-18	Initiated	Dougherty & Company	Buy

View All

Senseonics Holdings Inc Stock (SENS) Latest News

Nov 24, 2024

Senseonics (NYSE:SENS) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Nov 24, 2024

Nov 19, 2024

Senseonics Holdings Expands with Innovative Diabetes Solutions - TipRanks

Nov 19, 2024

Nov 16, 2024

StockNews.com Begins Coverage on Senseonics (NYSE:SENS) - MarketBeat

Nov 16, 2024

Senseonics Holdings (STU:6L6) Inventories, Raw Materials & Components : €0.23 Mil (As of Sep. 2024) - GuruFocus.com

Nov 16, 2024

Nov 15, 2024

Senseonics' (SENS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Nov 15, 2024

Nov 12, 2024

Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 12, 2024

Senseonics (SENS) to Present at Major Healthcare Conferences: Stifel and Canaccord | SENS Stock News - StockTitan

Nov 12, 2024

Nov 09, 2024

Senseonics Holdings, Inc. (AMEX:SENS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Earnings call: Senseonics reports Q3 results, FDA approval of Eversense 365 - Investing.com India

Nov 09, 2024

Nov 08, 2024

Senseonics Q3 2024 Earnings Preview - MSN

Nov 08, 2024

SENS stock touches 52-week low at $0.32 amid market challenges - Investing.com India

Nov 08, 2024